InvestorsHub Logo
icon url

Whalatane

04/07/20 10:30 PM

#263803 RE: jessellivermore #263791

Jl. u may have me on ignore ...BUT I agree with your post .
AMRN did the hard work and spend the $ to prove the benefit of high dose 96% pure EPA .... and that will save thousands if not millions from heart attacks and strokes

AMRN deserves the patent protection

Kiwi
icon url

Lemmiwinks

04/07/20 10:42 PM

#263813 RE: jessellivermore #263791

Jesse. The patents ruled as obvious had nothing or little to do with cardiovascular disease. They where about ldl reduction in PEOPLE with trigs over 500. Specifically in regards to aPO B.
No REDUCIT talk unless it somehow helps us block the generics.
icon url

daveymoore

04/07/20 11:19 PM

#263826 RE: jessellivermore #263791

the judiciary is just another group of government officials; the black robes do not make them special but they do make them scary imo
icon url

The Irishman

04/08/20 8:50 AM

#263879 RE: jessellivermore #263791

Doc JL...
I think you have me on ignore. So, others can hear me out.
The life saving factor of Vascepa ( new indication) must be taken into consideration. My questions is this: did the judge allow anything pertaining to Reduce-it into the trial?

Everyone on the planet knows that any generic approved will infringe on this new patent. How or why should this be overlooked? Do we all realize what this does to future innovation?

I agree with the good doctor. Some how and some way, this indication must be protected.